MoneyWorks4Me

NATCO Pharma informs about press release

10 Mar 2023 Evaluate

NATCO Pharma has informed that it enclosed a press release today titled ‘NATCO announces the Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the USA’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..